Neuroimaging of Ataxias

Current Clinical Neurology

Volumn 44, Issue , 2013, Pages 227-245

  D' Abreu, Anelyssa ^a   Cendes, Fernando ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATAXIA; ATAXIA TELANGIECTASIA; ATROPHY; AUTOSOMAL RECESSIVE SPASTIC ATAXIA; DIFFUSION TENSOR IMAGING; DISEASE COURSE; EPILEPSY; FRIEDREICH ATAXIA; GRAY MATTER; HUMAN; MORPHOMETRICS; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PONTINE TEGMENTUM ATROPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; SPINOCEREBELLAR DEGENERATION; TREMOR; VOXEL BASED MORPHOMETRY;

EID: 84897396514     PISSN: 15590585     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-471-5_14     Document Type: Article

References (102)

1. Klockgether T. Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol. 2010;9:94-104.
2. Abele M, Burk K, Schols L, et al. The aetiology of sporadic adult-onset ataxia. Brain. 2002;125:961-8.
3. Whaley NR, Fujioka S, Wszolek ZK. Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics. Orphanet J Rare Dis. 2011;6:33.
4. Degardin A, Dobbelaere D, Vuillaume I, et al. Spinocerebellar ataxia: a rational approach to aetiological diagnosis. Cerebellum. 2012;11(1):289-99.
5. Brusse E, Maat-Kievit JA, Van Swieten JC. Diagnosis and management of early- and late-onset cerebellar ataxia. Clin Genet. 2007;71:12-24.
6. Köllensperger M, Wenning GK. Assessing disease progression with MRI in atypical parkinsonian disorders. Mov Disord. 2009;24:S699-702.
7. Paulson HL. The spinocerebellar ataxias. J Neuroophthalmol. 2009;29:227-37.
8. Viau M, Boulanger Y. Characterization of ataxias with magnetic resonance imaging and spectroscopy. Parkinsonism Relat Disord. 2004;10:335-51.
9. Döhlinger S, Hauser T-K, Borkert J, Luft A, Schulz J. Magnetic resonance imaging in spinocerebellar ataxias. Cerebellum. 2008;7:204-14.
10. Ormerod IE, Harding AE, Miller DH, et al. Magnetic resonance imaging in degenerative ataxic disorders. J Neurol Neurosurg Psychiatry. 1994;57:51-7.
11. Nagaoka U, Suzuki Y, Kawanami T, et al. Regional differences in genetic subgroup frequency in hereditary cerebellar ataxia, and a morphometrical study of brain MR images in SCA1, MJD and SCA6. J Neurol Sci. 1999;164:187-94.
12. Murata Y, Kawakami H, Yamaguchi S, et al. Characteristic magnetic resonance imaging findings in spinocerebellar ataxia 6. Arch Neurol. 1998;55:1348-52.
13. Murata Y, Yamaguchi S, Kawakami H, et al. Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol. 1998;55:33-7.
14. Jacobi H, Hauser T-K, Giunti P, et al. Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings. Cerebellum. 2012;11:1-12.
15. Onodera O, Idezuka J, Igarashi S, et al. Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expandedCAGrepeats in theMJD1gene in Machado-Joseph disease. Ann Neurol. 1998;43:288-96.
16. Abe Y, Tanaka F, Matsumoto M, et al. CAGrepeat number correlates with the rate of brainstem and cerebellar atrophy in Machado-Joseph disease. Neurology. 1998;51:882-4.
17. Horimoto Y, Matsumoto M, Yuasa H, et al. Brainstem in Machado-Joseph disease: atrophy or small size? Eur J Neurol. 2008;15:102-5.
18. Yoshizawa T, Watanabe M, Frusho K, Shoji S. Magnetic resonance imaging demonstrates differential atrophy of pontine base and tegmentum in Machado-Joseph disease. J Neurol Sci. 2003;215:45-50.
19. D'Abreu A, Franca MC, Yasuda CL, Souza MSA, Lopes-Cendes I, Cendes F. Thalamic volume and dystonia in Machado-Joseph disease. J Neuroimaging. 2011;21:e91-3.
20. Giuffrida S, Saponara R, Restivo DA, et al. Supratentorial atrophy in spinocerebellar ataxia type 2: MRI study of 20 patients. J Neurol. 1999;246:383-8.
21. Ying SHM, Choi SIB, Perlman SLM, Baloh RWM, Zee DSM, Toga AWP. Pontine and cerebellar atrophy correlate with clinical disability in SCA2. Neurology. 2006;66:424-6.
22. Bang OY, Lee PH, Kim SY, Kim HJ, Huh K. Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis. J Neurol Neurosurg Psychiatry. 2004;75:1452-6.
23. Lukas C, Hahn H, Bellenberg B, et al. Spinal cord atrophy in spinocerebellar ataxia type 3 and 6. J Neurol. 2008;255:1244-9.
24. Ginestroni A, Della Nave R, Tessa C, et al. Brain structural damage in spinocerebellar ataxia type 1. J Neurol. 2008;255:1153-8.
25. D'Agata F, Caroppo P, Boghi A, et al. Linking coordinative and executive dysfunctions to atrophy in spinocerebellar ataxia 2 patients. Brain Struct Funct. 2011;216:275-88.
26. D'Abreu A, França MC Jr, Yasuda CL, Campos BAG, Lopes-Cendes I, Cendes F. Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study. J Neuroimaging. 2011. doi:101111/j1552-6569201100614×2011.
27. Alcauter S, Barrios FA, Diaz R, Fernandez-Ruiz J. Gray and white matter alterations in spinocerebellar ataxia type 7: an in vivo DTI and VBM study. Neuroimage. 2011;55:1-7.
28. Reetz K, Kleiman A, Klein C, et al. CAG repeats determine brain atrophy in spinocerebellar ataxia 17: a VBM study. PLoS One. 2011;6:e15125.
29. Reetz K, Lencer R, Hagenah J, et al. Structural changes associated with progression of motor deficits in spinocerebellar ataxia 17. Cerebellum. 2010;9:210-7.
30. Goel G, Pal PK, Ravishankar S, et al. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study. Parkinsonism Relat Disord. 2011;17:521-7.
31. Guerrini L, Lolli F, Ginestroni A, et al. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. Brain. 2004;127:1785-95.
32. Schulz JB, Borkert J, Wolf S, et al. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage. 2010;49:158-68.
33. Lukas C, Schöls L, Bellenberg B, et al. Dissociation of grey and white matter reduction in spinocerebellar ataxia type 3 and 6: a voxel-based morphometry study. Neurosci Lett. 2006;408:230-5.
34. Mandelli ML, De Simone T, Minati L, et al. Diffusion tensor imaging of spinocerebellar ataxias types 1 and 2. Am J Neuroradiol. 2007;28:1996-2000.
35. Della Nave R, Ginestroni A, Tessa C, et al. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics. Neuroimage. 2008;43:10-19.
36. Solodkin A, Peri E, Chen E, Ben-Jacob E, Gomez C. Loss of intrinsic organization of cerebellar networks in spinocerebellar ataxia type 1: correlates with disease severity and duration. Cerebellum. 2011;10:218-32.
37. Öz G, Hutter D, Tkác I, et al. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Mov Disord. 2010;25:1253-61.
38. Öz G, Iltis I, Hutter D, Thomas W, Bushara K, Gomez C. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum. 2011;10:208-17.
39. Boesch SM, Schocke M, Bürk K, et al. Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6. J Magn Reson Imaging. 2001;13:553-9.
40. Boesch SM, Wolf C, Seppi K, Felber S, Wenning GK, Schocke M. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging. J Magn Reson Imaging. 2007;25:564-9.
41. Hadjivassiliou M, Wallis LI, Hoggard N, Grünewald RA, Griffiths PD, Wilkinson ID. MR spectroscopy and atrophy in Gluten, Friedreich's and SCA6 ataxias. Acta Neurol Scand. 2011. doi:10.1111/j.1600-0404.2011.01620.x.
42. D'Abreu A, Franca M, Appenzeller S, Lopes-Cendes I, Cendes F. Axonal dysfunction in the deep white matter in Machado-Joseph disease. J Neuroimaging. 2009;19:9-12.
43. Yabe I, Tha KK, Yokota T, et al. Estimation of skeletal muscle energy metabolism in Machado- Joseph disease using P-31-MR spectroscopy. Mov Disord. 2011;26:165-8.
44. Wullner U, Reimold M, Abele M, et al. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6. Arch Neurol. 2005;62:1280-5.
45. Honjo K, Ohshita T, Kawakami H, et al. Quantitative assessment of cerebral blood flow in genetically confirmed spinocerebellar ataxia type 6. Arch Neurol. 2004;61:933-7.
46. Etchebehere EC, Cendes F, Lopes-Cendes I, Pereira JA, Lima MC, Sansana CR, Silva CA, Camargo MF, Santos AO, Ramos CD, Camargo EE. Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease. Arch Neurol. 2001;58:1257-63.
47. Taniwaki T ST, Kobayashi T, Kuwabara Y, Otsuka M, Ichiya Y, Masuda K, Goto I. Positron emission tomography (PET) in Machado-Joseph disease. J Neurol Sci. 1997;145:63-7.
48. Wang PS, Liu RS, Yang BH, Soong BW. Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6-a voxel-based FDG-positron emission tomography analysis. J Neurol. 2007;254:838-45.
49. Boesch SM, Donnemiller E, Müller J, et al. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-βCIT and 123I-IBZM SPECT study. Mov Disord. 2004;19: 1320-5.
50. Yen TC, Tzen KY, Chen MC, et al. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers. J Nucl Med. 2002;43:153-9.
51. Soong BW, Liu RS. Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease. J Neurol Neurosurg Psychiatry. 1998;64:499-504.
52. Kim J-M, Lee J-Y, Kim HJ, et al. The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6. J Neurol Neurosurg Psychiatry. 2010;81:529-32.
53. Soong B, Liu R, Wu L, Lu Y, Lee H. Metabolic characterization of spinocerebellar ataxia type 6. Arch Neurol. 2001;58:300-4.
54. Koeppen AH. Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci. 2011;303:1-12.
55. Koeppen A, Morral J, McComb R, Feustel P. The neuropathology of late-onset Friedreich's ataxia. Cerebellum. 2011;10:96-103.
56. De Michele G, Di Salle F, Filla A, et al. Magnetic resonance imaging in "typical" and "late onset" Friedreich's disease and early onset cerebellar ataxia with retained tendon reflexes. Ital J Neurol Sci. 1995;16:303-8.
57. Bhidayasiri R, Perlman SL, Pulst SM, Geschwind DH. Late-onset Friedreich ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature. Arch Neurol. 2005;62:1865-9.
58. Akhlaghi H, Corben L, Georgiou-Karistianis N, et al. Superior cerebellar peduncle atrophy in Friedreich's ataxia correlates with disease symptoms. Cerebellum. 2011;10:81-7.
59. França M, D'Abreu A, Yasuda C, et al. A combined voxel-based morphometry and 1H-MRS study in patients with Friedreich's ataxia. J Neurol. 2009;256:1114-20.
60. Della Nave R, Ginestroni A, Giannelli M, et al. Brain structural damage in Friedreich's ataxia. J Neurol Neurosurg Psychiatry. 2008;79:82-5.
61. Iltis I, Hutter D, Bushara KO, et al. 1H MR spectroscopy in Friedreich's ataxia and ataxia with oculomotor apraxia type 2. Brain Res. 2010;1358:200-10.
62. Della Nave R, Ginestroni A, Tessa C, et al. Brain white matter tracts degeneration in Friedreich ataxia.An in vivo MRI study using tract-based spatial statistics and voxel-based morphometry. Neuroimage. 2008;40:19-25.
63. Rizzo G, Tonon C, Valentino ML, et al. Brain diffusion-weighted imaging in Friedreich's ataxia. Mov Disord. 2011;26:705-12.
64. Anheim M, Tranchant C, Koenig M. The autosomal recessive cerebellar ataxias. N Engl J Med. 2012;366:636-46.
65. Palau F, Espinos C. Autosomal recessive cerebellar ataxias. Orphanet J Rare Dis. 2006;1:47.
66. Anheim M, Fleury M, Monga B, et al. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics. 2010;11:1-12.
67. Chun HH, Gatti RA. Ataxia-telangiectasia, an evolving phenotype. DNA Repair. 2004;3:1187-96.
68. Tavani F, Zimmerman RA, Berry GT, Sullivan K, Gatti R, Bingham P. Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI. Neuroradiology. 2003;45:315-9.
69. Ciemins JJ, Horowitz AL. Abnormal white matter signal in ataxia telangiectasia. Am J Neuroradiol. 2000;21:1483-5.
70. Wallis LI, Griffiths PD, Ritchie SJ, Romanowski CAJ, Darwent G, Wilkinson ID. Proton spectroscopy and imaging at 3 T in ataxia-telangiectasia. Am J Neuroradiol. 2007;28:79-83.
71. Firat AK, Muammer KH, Firat Y, Yakinci C. Quantitative evaluation of brain involvement in ataxia telangiectasia by diffusion weighted MR imaging. Eur J Radiol. 2005;56:192-6.
72. Berry-Kravis E, Abrams L, Coffey SM, et al. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord. 2007;22:2018-30.
73. Hashimoto R, Javan AK, Tassone F, Hagerman RJ, Rivera SM. A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome. Brain. 2011;134:863-78.
74. Adams JS, Adams PE, Nguyen D, et al. Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology. 2007;69:851-9.
75. Hashimoto R-I, Srivastava S, Tassone F, Hagerman RJ, Rivera SM. Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene. Mov Disord. 2011;26:1329-36.
76. Hashimoto R, Backer KC, Tassone F, Hagerman RJ, Rivera SM. An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS). J Psychiatr Res. 2011;45:36-43.
77. Martin M-H, Bouchard J-P, Sylvain M, St-Onge O, Truchon S. Autosomal recessive spastic ataxia of Charlevoix-Saguenay: a report of MR imaging in 5 Patients. Am J Neuroradiol. 2007;28:1606-8.
78. Gazulla J, Vela AC, Marín MA, et al. Is the ataxia of Charlevoix-Saguenay a developmental disease? Med Hypotheses. 2011;77:347-52.
79. Shimazaki H, Takiyama Y, Honda J, et al. Middle cerebellar peduncles and pontine T2 hypointensities in ARSACS. J Neuroimaging. 2013;23(1):82-5.
80. Anheim M, Monga B, Fleury M, et al. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain. 2009;132:2688-98.
81. Wenning GK, Litvan I, Tolosa E. Milestones in atypical and secondary Parkinsonisms. Mov Disord. 2011;26:1083-95.
82. Juh R, Pae C-U, Lee C-U, et al. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping. Neurosci Res. 2005;52:211-9.
83. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord. 2006;21:989-96.
84. Nicoletti G, Fera F, Condino F, et al. MRImaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease 1. Radiology. 2006;239:825-30.
85. Lee J-Y, Yun J, Shin C-W, Kim H-J, Jeon B. Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy. J Neurol. 2010;257:2065-70.
86. Kwon K-Y, Choi CG, Kim JS, Lee MC, Chung SJ. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease. Mov Disord. 2007;22:2352-8.
87. Kwon KY, Choi CG, Kim JS, Lee MC, Chung SJ. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of parkinsonian type multiple system atrophy from Parkinson's disease. Eur J Neurol. 2008;15:1043-9.
88. Blain CRVM, Barker GJP, Jarosz JMM, et al. Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology. 2006;67:2199-205.
89. Watanabe H, Saito Y, Terao S, et al. Progression and prognosis in multiple system atrophy. Brain. 2002;125:1070-83.
90. Marrannes J, Mulleners E. Hot cross bun sign in a patient with SCA-2. JBR-BTR 2009;92:263.
91. Lee YC, Liu CS, Wu HM, Wang PS, Chang MH, Soong BW. The 'hot cross bun' sign in the patients with spinocerebellar ataxia. Eur J Neurol. 2009;16:513-6.
92. Minnerop M, Specht K, Ruhlmann J, et al. Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage. 2007;36:1086-95.
93. Pellecchia MT, Barone P, Mollica C, et al. Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord. 2009;24:689-96.
94. Wang P-S, Wu H-M, Lin C-P, Soong B-W. Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology. 2011;53:471-81.
95. Bhattacharya K, Saadia D, Eisenkraft B, et al. Brain magnetic resonance imaging in multiplesystem atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol. 2002;59:835-42.
96. Kanazawa M, Shimohata T, Terajima K, et al. Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging. J Neurol. 2004;251:1121-4.
97. Brenneis C, Boesch SM, Egger KE, et al. Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry study. Mov Disord. 2006;21:159-65.
98. Hauser T-K, Luft A, Skalej M, et al. Visualization and quantification of disease progression in multiple system atrophy. Mov Disord. 2006;21:1674-81.
99. Specht K, Minnerop M, Abele M, Reul J, Wullner U, Klockgether T. In vivo voxel-based morphometry in multiple system atrophy of the cerebellar type. Arch Neurol. 2003;60:1431-5.
100. Tha KK, Terae S, Yabe I, et al. Microstructural white matter abnormalities of multiple system atrophy: in vivo topographic illustration by using diffusion-tensor MR imaging. Radiology. 2010;255:563-9.
101. Shiga K, Yamada K, Yoshikawa K, Mizuno T, Nishimura T, Nakagawa M. Local tissue anisotropy decreases in cerebellopetal fibers and pyramidal tract in multiple system atrophy. J Neurol. 2005;252:589-96.
102. Takado Y, Igarashi H, Terajima K, et al. Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectroscopy study. Mov Disord. 2011;26: 1297-302.